Last Posted: Nov 01, 2019
- The BRCA gene is about so much more than breast cancer risk
A Goldman, Well and Good, October 27, 2019 - Combined pathologic-genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay.
Gage M M et al. Annals of oncology : official journal of the European Society for Medical Oncology 2018 29(5) 1280-1285 - Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer.
Abulkhair Omalkhair et al. Journal of global oncology 2018 41-9 - Breast cancer risk assessment in patients who test negative for a hereditary cancer syndrome.
Breit Caroline et al. American journal of surgery 2019 Oct - Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
Zhang Yaqiong et al. DNA and cell biology 2019 Oct - Outcomes of women at high familial risk for breast cancer: An 8-year single-center experience.
Lammert Jacqueline et al. Asia-Pacific journal of clinical oncology 2019 Oct - Computer-aided diagnosis system for breast ultrasound images using deep learning.
Tanaka Hiroki et al. Physics in medicine and biology 2019 Oct - From Genetic Testing to Treatment and Prevention of BRCA-Related Breast Cancer.
Ki Chang Seok et al. Annals of laboratory medicine 2020 Mar 40(2) 99-100 - Untapped "-omics": the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment.
Komorowski A S et al. Breast cancer research and treatment 2019 Oct - Analysis Shows Women with High Breast Cancer Recurrence Scores Benefit from Chemo
NCI, October 25, 2019
.png)
No hay comentarios:
Publicar un comentario